Mark Identification

OCAS

Serial Number

76148225

Filing Date

Oct 16, 2000

Registration Date

Apr 1, 2008

Trademark by

ASTELLAS PHARMA INC.

Classification Information

CONTROLLED RELEASE DELIVERY FORMULATION SOLD AS AN INTEGRAL COMPONENT OF ORAL PHARMACEUTICAL PREPARATIONS PROVIDING CONTINUING DRUG RELEASE AND ABSORPTION FOR A PROLONGED PERIOD OF TIME FOR THE TREATMENT OF DISEASE OR HEALTH-RELATED CONDITIONS INVOLVING BLOOD AND BLOOD-FORMING ORGANS, THE CARDIAC CIRCULATORY SYSTEMS, THE PERIPHERAL VASCULAR CIRCULATORY SYSTEM, THE ENDOCRINE SYSTEM, THE GENITOURINARY SYSTEM, THE IMMUNE SYSTEM, INFECTIOUS AND PARASITIC CONDITIONS, THE UPPER AND LOWER DIGESTIVE SYSTEM, MENTAL DISORDERS, METABOLIC DISORDERS, MULTI-SYSTEM AND ILL DEFINED CONDITIONS, MUSCULOSKELETAL SYSTEMS AND CONNECTIVE TISSUE, NEOPLASMS, THE NERVOUS SYSTEM, NUTRITIONAL DISORDERS, PREGNANCY, THE RESPIRATORY SYSTEM, SENSORY ORGAN CONDITIONS, SKIN AND SUBCUTANEOUS CONDITIONS

Pharmaceuticals

MANUFACTURE OF ORAL CONTROLLED- RELEASE PHARMACEUTICAL PRODUCTS TO THE ORDER OR SPECIFICATION OF OTHERS

Treatment of Materials